SCHEMBL9768858

SCHEMBL9768858

NN=C(c1ccccc1)c1ccncc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.54
MEN1 O00255 1/20 0.54
ALDH1A1 P00352 7/20 0.49
CYP1A2 P05177 2/20 0.49
CYP3A4 P08684 2/20 0.49
CYP2D6 P10635 2/20 0.49
CYP2C9 P11712 2/20 0.49
HPGD P15428 2/20 0.49
CYP2C19 P33261 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
PLOD2 O00469 1/20 0.48
PLOD3 O60568 1/20 0.48
PLOD1 Q02809 1/20 0.48
HIF1A Q16665 1/20 0.48
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
POLB P06746 1/20 0.45
BCHE P06276 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44
CYP19A1 P11511 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18787394 1.00 KMT2A (0.54) KMT2AMEN1ALDH1A1CYP1A2CYP3A4
Water SCHEMBL9769054 0.98 KMT2A (0.52) KMT2AMEN1ALDH1A1CYP1A2CYP3A4
Hydrochloric Acid SCHEMBL9769057 0.98 KMT2A (0.52) KMT2AMEN1ALDH1A1CYP1A2CYP3A4
SCHEMBL16089348 0.86 BLM (0.43) KMT2AMEN1ALDH1A1CYP3A4HPGD
SCHEMBL1141828 0.86 BLM (0.43) KMT2AMEN1ALDH1A1CYP3A4HPGD
Iodide SCHEMBL27950655 0.84 BLM (0.42) KMT2AMEN1ALDH1A1CYP3A4HPGD
SCHEMBL9529419 0.80 KMT2A (0.56) KMT2AMEN1ALDH1A1CYP1A2CYP3A4
SCHEMBL17338842 0.75 CYP19A1 (0.41) KMT2AALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL17338844 0.75 CYP19A1 (0.41) KMT2AALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL28267335 0.74 ESR1 (0.55) KMT2AMEN1ALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3154941-B1 SMALL MOLECULE LFA-1 INHIBITORS ALLOCYTE PHARMACEUTICALS AG (CH) 2021-01-20 EP disclosed
CN-106470973-B Small molecule L FA-1 inhibitor 阿罗赛特制药公司 2020-08-04 CN disclosed
US-20190040008-A1 SMALL MOLECULE LFA-1 INHIBITORS ALLOCYTE PHARMACEUTICALS AG (CH) 2019-02-07 US disclosed
US-10077238-B2 Small molecule LFA-1 inhibitors ALLOCYTE PHARMACEUTICALS AG (CH) 2018-09-18 US disclosed
US-20170121284-A1 SMALL MOLECULE LFA-1 INHIBITORS ALLOCYTE PHARMACEUTICALS AG (CH) 2017-05-04 US disclosed
US-5023334-A Anthelmintic pyridinyl acylhydrazones THE UPJOHN COMPANY (US) 1991-06-11 US disclosed
US-5011932-A Anthelmintic pyridinyl acylhydrazones derivatives UPJOHN COMPANY (US) 1991-04-30 US disclosed
EP-0214158-A1 ANTHELMINTIC PYRIDINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS THE UPJOHN COMPANY (US) 1987-03-18 EP disclosed
WO-1986004582-A1 ANTHELMINTIC PYRIDINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS THE UPJOHN COMPANY (US) 1986-08-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10077238-B2 Small molecule LFA-1 inhibitors ICAM1, VCAM1, ITGB1 KMT2A 1882/4885MEN1 3973/4885ALDH1A1 153/4885
US-20190040008-A1 SMALL MOLECULE LFA-1 INHIBITORS ICAM1, VCAM1, ITGB1 KMT2A 1882/4885MEN1 3973/4885ALDH1A1 153/4885
US-20170121284-A1 SMALL MOLECULE LFA-1 INHIBITORS ICAM1, VCAM1, ITGB1 KMT2A 1882/4885MEN1 3973/4885ALDH1A1 153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.